Breast implant removal — commonly called explant surgery — is a legitimate, frequently performed procedure undertaken for medical, aesthetic, and personal reasons. It is not an admission of failure; implants are not lifetime devices, and removal or exchange is a normal part of long-term implant care for many patients. This page covers the full procedure overview; for deeper detail on all removal options and the en bloc debate, see our comprehensive breast implant removal guide. If breast implant illness is part of your decision, see our breast implant illness page for what current evidence does and does not show.
What Is Explant Surgery?
Explant surgery removes one or both breast implants through an incision — typically reopening the original augmentation scar (inframammary, periareolar, or transaxillary depending on prior surgery). The procedure sounds straightforward, but what happens to the scar tissue capsule that formed around the implant is a separate decision with meaningful implications for recovery, cost, and outcome.
ASPS describes breast implant removal as addressing patient concerns including contracture, rupture, implant malposition, or desire to no longer have implants.1 Removal alone — taking out the implant and leaving the capsule in place — is sometimes appropriate when the capsule is thin and benign. More often, some form of capsulectomy (capsule removal) accompanies explant.
Patients should bring prior operative records when available — implant manufacturer, fill type, volume, and placement depth help the surgeon anticipate capsule thickness and plan capsulectomy approach. Unknown implant history does not prevent removal but may require intraoperative assessment and imaging review when records exist elsewhere.
Common Reasons for Removal
Capsular contracture — firm, sometimes painful scar tissue tightening around the implant — is among the most common medical reasons for reoperation. Graded on the Baker scale (I–IV), higher grades cause visible distortion and discomfort. Rupture — silent for silicone (detected on imaging) or obvious for saline (visible deflation) — prompts removal regardless of symptoms.
Size or preference change drives many removals: patients who want smaller breasts, no implants, or a different type may choose explant rather than exchange. BIA-ALCL (breast implant-associated anaplastic large cell lymphoma) requires implant and capsule removal as treatment — primarily linked to textured surfaces. Consensus guidelines address diagnosis and management of BIA-ALCL, distinct from routine elective explant.3
Breast implant illness (BII) — a constellation of systemic symptoms some patients attribute to their implants — motivates removal for a subset of patients. The evidence base remains limited; symptom improvement after explant is reported anecdotally but not consistently demonstrated in controlled studies. FDA labeling explicitly distinguishes BII from BIA-ALCL and notes that research into BII is ongoing.2 Honest consultation should not overpromise symptom resolution.
Implant age alone is not a medical indication for removal — but older implants have higher cumulative rupture risk on imaging surveillance, and many patients choose proactive removal or exchange as implants approach the 10-to-20-year mark discussed during original consent. Documenting implant manufacturer, model, and placement date helps your surgeon plan removal technique and assess rupture risk.
Removal Options
Implant removal alone: The implant is removed; the capsule may be left in place if thin and asymptomatic. Simplest recovery, but retained capsule tissue is not acceptable to all patients.
Total capsulectomy: The scar capsule is removed along with the implant — standard approach when contracture, thick capsule, or patient preference warrants complete tissue removal. The capsule is typically opened to remove the implant first, then the remaining capsule tissue is excised.
En bloc capsulectomy: The implant and surrounding capsule are removed together as one intact unit without opening the capsule during surgery. Some patients request this technique believing it reduces exposure to implant contents or biofilm. The evidence for a definitive additional safety or symptom benefit over standard total capsulectomy is not conclusively established in peer-reviewed literature — a point worth discussing candidly with your surgeon rather than assuming en bloc as mandatory standard of care.
Combined procedures: Explant may be combined with a breast lift (mastopexy) if skin has stretched or ptosis has developed since original augmentation; with fat transfer for modest volume restoration without a new implant; or with direct-to-implant exchange if the goal is different size or type rather than removal. Combined lift-plus-explant produces longer incisions and recovery but addresses contour in one stage.
Capsule send-out for pathology may be recommended when BIA-ALCL is suspected or when thick, unusual capsule tissue is encountered — your surgeon should explain when pathology is standard versus optional. Biofilm within the capsule is an area of active research linked to contracture and BII discussions, but routine culture of all capsules is not universal practice.
Recovery Timeline
Recovery depends heavily on whether capsulectomy, lift, or fat transfer is combined with simple removal.
Days 1–3: Soreness, swelling, and bruising. Pain managed with oral medication. Drains may be placed if extensive dissection or lift is performed. Arm movement limited initially; many patients can walk and manage self-care.
Days 4–14: Most patients return to desk work within one to two weeks for straightforward explant without lift. Drain care follows surgeon protocol. Compression garments or surgical bras support healing per instructions.
Arm elevation and limited reaching reduce tension on chest incisions during the first week — particularly when capsulectomy creates a larger dissection field than simple implant removal. Sleep elevated on pillows if recommended to minimize swelling.
Weeks 3–8: Gradual return to exercise, typically avoiding chest-heavy lifting until weeks 4 to 6 or later. Swelling subsides progressively over weeks to months. See our post-surgery warning signs guide for symptoms requiring urgent attention.
Months 3–6: Final breast contour becomes apparent once swelling fully resolves — particularly relevant if a lift was combined. Without a lift, breasts may appear deflated or sagging compared with the implanted state; this is an expected outcome that should be discussed pre-operatively.
Results After Removal
What your breasts look like after explant depends on how long implants were in place, original tissue volume, skin elasticity, and whether a lift or fat transfer was performed. Patients with substantial native breast tissue before augmentation often return to a satisfactory natural contour. Patients who were very small pre-augmentation and wore large implants for many years frequently have significant ptosis and deflation — a lift is commonly recommended and should be part of pre-operative planning, not an afterthought.
Symptom improvement after explant for patients with BII concerns is variable and not guaranteed. Some patients report improvement in fatigue, joint pain, or cognitive symptoms; others do not. Research is ongoing and should not be overstated in either direction. Our full removal guide covers the en bloc debate and post-removal expectations in more depth.
Patients removing implants without a lift should preview expected deflation with their surgeon — reviewing photos of explant-only results in patients with similar pre-augmentation tissue helps calibrate expectations. "Going flat" is a valid aesthetic choice for many patients; others prefer lift or fat transfer to restore breast shape without re-implanting.
Insurance Coverage
Insurance coverage depends heavily on the documented reason. Confirmed rupture, symptomatic capsular contracture (often Baker grade III–IV), or BIA-ALCL diagnosis may support medical-necessity claims with appropriate documentation — imaging, operative notes, pathology when applicable. Removal for personal preference, BII without a recognized medical diagnosis, or elective size change is typically not covered.
Pre-authorization requirements, required imaging, and in-network surgeon rules vary by insurer. See our insurance coverage guide for general documentation criteria. Even when removal is covered, a combined cosmetic lift usually is not — patients should clarify what portions of a combined procedure may be eligible.
Out-of-network explant for BII-related concerns is common when patients seek specific surgeons — but insurance reimbursement may be lower or denied entirely. Understanding financial exposure before surgery avoids billing surprises, particularly when en bloc technique or combined lift increases total cost substantially.
Cost
Explant in the US typically costs $5,000 to $10,000 total depending on technique complexity — simple removal at the lower end, total capsulectomy or en bloc in the middle, and combined lift or fat transfer toward the upper end. En bloc technique may carry higher surgeon fees due to operative difficulty and time.
Quotes should itemize surgeon, anesthesia, facility, pathology (if capsule sent for analysis), and follow-up. Comparing explant cost to original augmentation is not apples-to-apples — capsulectomy adds operative time beyond simple implant swap. See our cost guide for broader comparisons and our financing guide for payment options. ASPS statistics reflect growing interest in implant removal alongside augmentation.4
Patients exchanging rather than removing implants — switching size, type, or addressing contracture with new devices — follow a related but distinct surgical path covered on our implant types page and augmentation overview. Explant-only planning should not assume exchange is the default next step unless that is your stated goal.
Post-explant mammography may show different tissue patterns than pre-augmentation baselines — inform radiologists of explant date and whether capsulectomy was performed. New baseline imaging after healing completes helps future screening comparisons and documents post-explant breast architecture accurately.
Frequently Asked Questions
Why do people have implants removed?
Common reasons include capsular contracture, suspected or confirmed rupture, a desire for a size change, or personal choice, including concern about breast implant illness. See our full breast implant illness guide for what current evidence does and doesn't show about that specific concern.
Will I need a lift after removal?
Some patients do, depending on skin elasticity and how much the breast tissue has changed since the original implant surgery — this is assessed on individual exam, not assumed automatically. A lift can be performed at the same time as removal or as a separate, later procedure.
Does insurance cover implant removal?
It depends on the reason — removal for a documented rupture or contracture may have a stronger case for coverage than removal for personal preference alone. See our insurance coverage guide for general documentation criteria insurers apply.
What is "en bloc" removal?
It's a technique where the implant and its surrounding scar capsule are removed together as one intact unit, sometimes requested by patients concerned about implant illness. The evidence for a definitive additional safety benefit over standard capsulectomy is not conclusively established — discuss this candidly with your surgeon.
How long is explant recovery?
Most patients return to non-strenuous activity within one to two weeks. Recovery extends longer if a lift or extensive capsulectomy is combined.
Can fat transfer restore volume after removal?
Yes — some patients combine removal with fat transfer for modest volume restoration without a new implant. See our fat transfer overview for survival-rate data and realistic volume expectations.